News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeurogesX, Inc. (NGSX) Receives Additional Notice of Allowance Covering NGX-1998 in U.S.


8/2/2012 9:48:31 AM

SAN MATEO, Calif., Aug. 2, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (OTCQB:NGSX) (OTCBB:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it has received an additional notice of allowance from the United States Patent and Trademark Office (USPTO) related to the company's family of patents for NGX-1998, the Company's next generation liquid formulation of prescription-strength capsaicin.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES